Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
3SBio ( (HK:1530) ) has shared an update.
3SBio shareholders have approved an ordinary resolution at an extraordinary general meeting held on 23 April 2026 to distribute all shares of subsidiary Mandi Inc. as a conditional special dividend in specie. The vote, overseen by Computershare Hong Kong Investor Services as scrutineer, passed with 99.995% support and grants the board broad authority to determine the exact distribution mechanics, advancing the planned spin-off and potentially reshaping the group’s capital structure and asset portfolio.
With no voting restrictions or stated plans by any party to oppose or abstain, the outcome reflects strong investor backing for the spin-off strategy. The move signals management’s intent to unlock value from Mandi Inc. for qualifying shareholders while giving directors flexibility to finalize record dates, allocation formulas, and transfer arrangements within applicable legal and regulatory requirements.
The most recent analyst rating on (HK:1530) stock is a Hold with a HK$29.43 price target. To see the full list of analyst forecasts on 3SBio stock, see the HK:1530 Stock Forecast page.
More about 3SBio
3SBio Inc., incorporated in the Cayman Islands and listed in Hong Kong, operates in the biopharmaceutical sector. The company focuses on developing and commercializing innovative therapies, and it maintains a substantial shareholder base with more than 2.5 billion issued shares eligible to vote on key corporate actions.
Average Trading Volume: 27,729,236
Technical Sentiment Signal: Buy
Current Market Cap: HK$62.99B
For a thorough assessment of 1530 stock, go to TipRanks’ Stock Analysis page.